Functional Study of Splicing Xbp-1 in the Kidney Injury by Using Tet-On System in Vitro and in Vivo (III) = 利用Tet-on系統於細胞及基因轉殖鼠模型研究剪接型XBP-1於腎臟損傷之功能 (III)

Project title
利用Tet-on系統於細胞及基因轉殖鼠模型研究剪接型XBP-1於腎臟損傷之功能 (III)
Internal ID
MOST104-2314-B002-126-MY3
Principal Investigator
CHIH-KANG CHIANG
Start Date
August 1, 2017
End Date
July 31, 2018
Investigators
KUAN-YU HUNG
SHING-HWA LIU
Organizations
Toxicology
Partner Organizations
National Science and Technology Council
Description
Chronic kidney disease has emerged as a global public health burden. The prevalence of end-stage renal disease (ESRD) in Taiwan stands at the highest ranking in the world. Acute kidney injury (AKI), AKI to chronic kidney disease (CKD) continuum and CKD all will lead to ESRD as a common ending of kidney diseases. However, pathological analysis of biopsy samples from patients with ESRD commonly reveals impaired glomeruli and tubulointerstitial fibrosis. Accumulating evidence has emphasized the important role of chronic hypoxia in the tubulointerstitium in the final common pathway that leads to development of ESRD. Chronic hypoxia triggers cellular stresses, including endoplasmic reticulum (ER) stress, oxidative stress and mitochondrial stress. In parallel, energy loss owing to aberrant oxygen metabolism decreases ER and mitochondrial function. The ER is a key cellular organelle for protein maturation, and approximately one-third of all cellular proteins (including secretory, lumenal, and membrane proteins) are translocated into the lumen of the ER, where they are modified to form their proper tertiary structure by ER-resident enzymes and chaperones. Protein homeostasis, or proteostasis, is conducted via sophisticated networks of mechanisms that act to maintain the quality of proteins and the evolutionary diversity of the biological functions of proteins. Therefore, proteostasis exerts substantial influence on cell homeostasis or, in other words, on cell fate. Insufficient proteostasis has been suggested to have a pathophysiological role in various diseases, such as Parkinson disease and Alzheimer disease. Recently, renal pathogenic factors that include proteinuria, uraemic toxins and metabolic derangement act in association with renal cell dysfunction to disrupt proteostasis. Thus, normalization of ER proteostasis might, therefore, be effective and novel for cell maintenance, and protect against kidney pathologies. Splicing X-Box binding protein-1 (sXBP-1) catalyzes the unconventional processing of the mRNA, plays the central roles to activate the ER proteostasis. sXBP1 involved in different processes including (a) Metabolic and redox, (b) Apoptosis, (c) Autophagy, (d) ER-associated degradation (ERAD), (e) chaperones and foldases and (f) vesicle trafficking. Regardless of etiology, all patients with chronic renal disease show a progressive decline in renal function with time. Chronic inflammation and diabetes are associated with renal fibrosis, is a key factor of this pathophysiologic changes. Our recent publication demonstrated the down-regulation of ER proteostasis in the ischemia/ reperfusion AKI and chronic unilateral ureteral obstruction CKD model. We believe that selective activation of splicing XBP1 pathway might play a role in overcoming the kidney insult. By using Tet-on splicing XBP1 transgene in vitro and in vivo, we can explore the salvage mechanisms in AKI and chronic renal fibrosis. We will further explore the potential targets via metabolomics and transcriptomics within the 3 years’ project. In the first year, we will study the rescue ability of Tet-on splicing XBP1 gene in cellular models of acute and chronic kidney injury. In the second year, we will generate kidney-specific Tet-on splicing XBP1 transgenic mice, and study the consequences of the splicing XBP1 overexpression by passing the traditional adaptive ER proteostasis in acute and chronic kidney and metabolic stress mice model. In the third year, we will investigate the metabolomics and transcriptomics profiles of Tet-on splicing XBP-1 systems in vitro and in vivo. Using these available tools will help us to develop a novel approach in ER proteostasis, which might be a new convincing treatment approach in kidney diseases.

臺大位居世界頂尖大學之列，為永久珍藏及向國際展現本校豐碩的研究成果及學術能量，圖書館整合機構典藏（NTUR）與學術庫（AH）不同功能平台，成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動，應用在學術研究上是透過將研究著作公開供使用者自由取閱，以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力，NTU Scholars即為本校的開放取用典藏（OA Archive）平台。（點選深入了解OA）

  • 請確認所上傳的全文是原創的內容，若該文件包含部分內容的版權非匯入者所有，或由第三方贊助與合作完成，請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔，可使用Open policy finder網站查詢，以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science